KENDALL CAPITAL MANAGEMENT – Emergent BioSolutions Inc. Transaction History
KENDALL CAPITAL MANAGEMENT portfolio value:
$239,000
portfolio value
KENDALL CAPITAL MANAGEMENT quarter portfolio value change:
-32.38%
quarter
Emergent BioSolutions Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -115K | $20.99 | 11.39K | |
| Q2 2022 | share | Decrease | -1.64% | -190 shares | -122K | $31.04 | 11.39K |
| Q1 2022 | share | Increase | +4.75% | 525 shares | -5K | $41.06 | 11.58K |
| Q4 2021 | share | Increase | +38.16% | 3.05K shares | 80K | $45.14 | 11.06K |
| Q3 2021 | share | Increase | +82.14% | 3.61K shares | 124K | $50.07 | 8.00K |
| Q2 2021 | share | Increase | 0.00% | 4.39K shares | 277K | $62.99 | 4.39K |